118 related articles for article (PubMed ID: 34699278)
21. Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study.
Spoerl S; Gerken M; Schimnitz S; Taxis J; Fischer R; Lindner SR; Ettl T; Ludwig N; Spoerl S; Reichert TE; Spanier G
Curr Oncol; 2022 Dec; 29(12):9660-9670. PubMed ID: 36547172
[TBL] [Abstract][Full Text] [Related]
22. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
23. Sex- and Site-Related Significance in Cutaneous Head and Neck Melanoma.
Košec A; Rašić I; Pegan A; Solter D; Ćurković M; Bedeković V
Ear Nose Throat J; 2021 Jun; 100(5):343-349. PubMed ID: 31547714
[TBL] [Abstract][Full Text] [Related]
24. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in head and neck melanoma according to facial aesthetic units.
Paolino G; Cardone M; Didona D; Moliterni E; Losco L; Corsetti P; Schipani G; Lopez T; Calvieri S; Bottoni U
G Ital Dermatol Venereol; 2020 Feb; 155(1):41-45. PubMed ID: 28748684
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
[TBL] [Abstract][Full Text] [Related]
27. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
28. Survival Differences Between Pediatric Head and Neck Versus Body Melanoma in the Surveillance, Epidemiology, and End Results Program.
Shi K; Camilon PR; Roberts JM; Meier JD
Laryngoscope; 2021 Feb; 131(2):E635-E641. PubMed ID: 32364637
[TBL] [Abstract][Full Text] [Related]
29. Tumor location predicts survival in cutaneous head and neck melanoma.
Tseng WH; Martinez SR
J Surg Res; 2011 May; 167(2):192-8. PubMed ID: 21176922
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of 39 cases of pediatric cutaneous head and neck melanoma.
Tcheung WJ; Marcello JE; Puri PK; Abernethy AP; Nelson KC
J Am Acad Dermatol; 2011 Aug; 65(2):e37-e42. PubMed ID: 21075477
[TBL] [Abstract][Full Text] [Related]
31. Risk and Survival of Patients with Head and Neck Cutaneous Melanoma: National Perspective.
Al-Qurayshi Z; Hassan M; Srivastav S; Sperry S; Pagedar N; Hamner J; Kandil E
Oncology; 2017; 93(1):18-28. PubMed ID: 28423377
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group.
Ringborg U; Afzelius LE; Lagerlöf B; Adami HO; Augustsson I; Blomqvist E; Boeryd B; Carlin E; Edström S; Eldh J
Cancer; 1993 Feb; 71(3):751-8. PubMed ID: 8431856
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma.
Law MM; Wong JH
Am Surg; 1994 May; 60(5):362-6. PubMed ID: 8161088
[TBL] [Abstract][Full Text] [Related]
34. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival].
Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO
Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837
[TBL] [Abstract][Full Text] [Related]
35. Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision.
Hanson J; Demer A; Liszewski W; Foman N; Maher I
J Am Acad Dermatol; 2020 Jan; 82(1):149-155. PubMed ID: 31473297
[TBL] [Abstract][Full Text] [Related]
36. Analyzing County-level Social Vulnerabilities of Head and Neck Melanomas in the United States.
McCampbell L; Fei-Zhang DJ; Chelius D; Rastatter J; Sheyn A
Laryngoscope; 2024 Jan; 134(1):185-190. PubMed ID: 37341511
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and epidemiological characteristics of cutaneous and mucosal head and neck melanoma.
Berzina A; Azarjana K; Cema I; Pjanova D; Rivosh A
Stomatologija; 2011; 13(2):49-54. PubMed ID: 21822045
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in head and neck melanoma. Effect of lesion location.
Wanebo HJ; Cooper PH; Young DV; Harpole DH; Kaiser DL
Cancer; 1988 Aug; 62(4):831-7. PubMed ID: 3395962
[TBL] [Abstract][Full Text] [Related]
39. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
[TBL] [Abstract][Full Text] [Related]
40. Geographic region: Does it matter in cutaneous melanoma of the head and neck?
Kılıç S; Unsal AA; Chung SY; Samarrai R; Kılıç SS; Baredes S; Eloy JA
Laryngoscope; 2017 Dec; 127(12):2763-2769. PubMed ID: 28581118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
